Immediate complications of surgical abortion;Complications immédiates de l'IVG chirurgicale

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 35, Issue 2, 2006, Pages 157-162

  Soulat, C ^a   Gelly, M ^a  

^a HÔPITAL LOUIS MOURIER   (France)

Author keywords

Ambulatory surgical procedures; Intraoperative complications; Legal abortion; Surgical abortion; Uterine suction

Indexed keywords

ABORTION; BLEEDING; FRANCE; GENERAL ANESTHESIA; HUMAN; ILLEGAL ABORTION; INDUCED ABORTION; LOCAL ANESTHESIA; MEDICAL LITERATURE; MORTALITY; POSTOPERATIVE COMPLICATION; REVIEW; RISK ASSESSMENT; SURGICAL TECHNIQUE; THERAPEUTIC ABORTION; UTERINE CERVIX DISEASE; UTERUS PERFORATION; VACUUM ASPIRATION; COMPARATIVE STUDY; CURETTAGE; FEMALE; INJURY; PREGNANCY; RISK FACTOR; UTERINE CERVIX; UTERUS; UTERUS BLEEDING;

ABORTION, INDUCED; ANESTHESIA, GENERAL; ANESTHESIA, LOCAL; CERVIX UTERI; FEMALE; HUMANS; PREGNANCY; RISK FACTORS; UTERINE HEMORRHAGE; UTERUS; VACUUM CURETTAGE;

EID: 33646682843     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0368-2315(06)76389-X     Document Type: Article

References (29)

1. Birman C. L'IVG en Île-de-France. Programme régional de santé : périnatalité. Synthèse d'enquêtes. Rapport d'étape. Décembre 2001.
2. ANAES, Service des recommandations et références professionnelles. Prise en charge de l'interruption volontaire de grossesse jusqu'à 14 semaines. Mars 2001.
3. Vilain A. Les IVG en 2003. Études et résultats. DREES, 2005, p. 431.
4. Nisand I. L'IVG en France, propositions pour diminuer les difficultés que rencontrent les femmes. Paris : La documentation française, 1999.
5. Grimes DA, Creinin MD. Induced abortion: an overview for internists. Ann Intern Med 2004; 140: 620-6.
6. Koonin LM, Smith JC, Ramick M, Strauss LT, Hopkins FW. Abortion surveillance: United States, 1993 and 1994. MMWR CDC Surveill Summ 1997; 46: 37-98.
7. Lawson HW, Frye A, Atrash HK, Smith JC, Shulman HB, Ramick M. Abortion mortality, United States, 1972-1987. Am J Obstet Gynecol 1994; 171: 1365-72.
8. Bartlett LA, Berg CJ, Schulman HB, Zane SB, Green CA, Whitehead S et al. Risk factors for legal induced abortion-related mortality in the United States. Obstet Gynecol 2004; 103: 729-37.
9. Peterson HB, Grimes DA, Cates W, Rubin GL. Comparative risk of death from induced abortion at < or = 12 weeks of gestation performed with local versus general anaesthesia. Am J Obstet Gynecol 1981; 141: 763-8.
10. Hakim-Elahi E, Towell HM, Burnhill MS. Complications of first-trimester abortion: a report of 170000 cases. Obstet Gynecol 1990; 76: 129-35.
11. Department of Health. Reports on confidential enquiries into maternal deaths in the United Kingdom: 1985-87. London: HMSO; 1991/1988-1990. London: HMSO; 1994/1991-1993. London: HMSO; 1996/1994-1996. London: HMSO; 1998.
12. Ferris LE, McMain-Klein M, Colodny N, Fellows GF, Lamont J. Factors associated with immediate abortion complications. Can Med Assoc J 1996; 154: 1677-85.
13. e Journées internationales d'études sur l'avortement et la contraception. Lille, ANCIC, 2003, p. 53-9.
14. Kaali SG, Szigetvari IA, Bartfai GS. The frequency and management of uterine perforations during first-trimester abortion. Am J Obstet Gynecol 1989; 161: 406-8.
15. Grimes DA, Schultz KF, Cates W, Tyler CW. Local versus general anesthesia: wich is safer for performing suction curettage abortions? Am J Obstet Gynecol 1979; 135: 1030-5.
16. Chen LH, Lai SF, Lee WH, Leong KY. Uterine perforation during elective first-trimester abortions: a 13-year revue. Singapore Med J 1995; 36: 63-7.
17. Thonneau P, Poirel H, Fougeyrollas B, Maria B, Meyer L, Goepp A et al. A comparative analysis of fall in haemoglobin following abortions conducted by mifepristone (600 mg) and vacuum aspiration. Hum Reprod 1995; 10: 1512-5.
18. Thonneau P, Fougeyrollas B, Ducot B, Boubilley D, Dif J, Lalande M et al. Complications of abortion performed under local anesthesia. Eur J Obstet Gynecol Reprod Biol 1998; 81: 15-63.
19. Bacle F, Boufassa F, Lambert J, Lefebvre P, Soulat C, Meyer L. Conditions de réalisation et complications précoces des IVG entre 12 et 14 semaines d'aménorrhée comparées aux IVG entre 8 et 12 semaines d'aménorrhée. J Gynecol Obstet Biol Reprod 2005 ; 34 : 339-45.
20. Blanchard S. Les femmes pourront désormais avorter chez leur médecin. Le Monde, 24 juillet 2004, p. 5.
21. Bouvier-Colle MH, Deneux C, Szego E, Coet C, Michel E, Varnoux N et al. Estimation de la mortalité maternelle en France : une nouvelle méthode. J Gynecol Obstet Biol Reprod 2004 ; 33 : 421-9.
22. Silvestre L, Dubois C, Renault M, Rezvani Y, Baulieu EE, Ulman A. Voluntary interruption of pregnancy wih mifepristone and a prostaglandin analogue. New Engl J Med 1990; 322: 645-8.
23. Ulmann A, Silvestre L, Chemama L, Rezvani Y, Renault M, Aguillaume C et al. Medical termination of pregnancy with mifepristone followed by a prostaglandin analogue. Acta Obstet Gynecol Scand 1992; 71: 278-83.
24. Peyron R, Aubény E, Targosz V, Silvestre L, Renault M, Elkik F et al. Early termination of pregnancy with mifepristone and the orally active prostaglandin misoprostol. New Engl J Med 1993; 328: 1509-13.
25. Grimes DA. Medical abortion in early pregnancy: a review of the evidence. Obstet Gynecol 1997; 89: 790-6.
26. Spitz I, Bardin CW, Benton L, Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. New Engl J Med 1998; 338: 1241-7.
27. Schaff E, Eisinger S, Sradalius L, Franks P, Gore B, Poppema S. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception 1999; 59: 1-6.
28. Jensen J, Astley S, Morgan E, Nichols M. Outcomes of suction curettage and mifepristone abortion in the United States. Contraception 1999; 59: 153-9.
29. Hausknecht R. Mifepristone and misoprostol for early medical abortion: 18 months experience in the United States. Contraception 2003; 67: 463-5.